Human health screening and public health significance of contaminants of emerging concern detected in public water supplies
Authors:
- Robert BensonRBRobert Benson
- Octavia D. ConerlyOCOctavia D. Conerly
- William SanderWSWilliam Sander
- Angela L. BattABAngela L. Batt
- J. Scott BooneJBJ. Scott Boone
- Edward T. FurlongEFEdward T. Furlong
- Susan T. GlassmeyerSGSusan T. Glassmeyer
- Dana W. KolpinDKDana W. Kolpin
- Heath E. MashHMHeath E. Mash
- Kathleen M. SchenckKSKathleen M. Schenck
- Jane Ellen SimmonsJSJane Ellen Simmons
- 1 February 2017
- journal article
- Published by Elsevier in Science of The Total Environment
- Vol. 579, 1643-1648
Abstract
No abstract availableKeywords
Funding Information
- U.S. Environmental Protection Agency (DW14922330)
This publication has 14 references indexed in Scilit:
- Comparison of in vitro estrogenic activity and estrogen concentrations in source and treated waters from 25 U.S. drinking water treatment plantsScience of The Total Environment, 2017
- Neurobehavioral Function in School-Age Children Exposed to Manganese in Drinking WaterEnvironmental Health Perspectives, 2014
- Lithium in drinking water and suicide mortalityThe British Journal of Psychiatry, 2011
- Intellectual Impairment in School-Age Children Exposed to Manganese from Drinking WaterEnvironmental Health Perspectives, 2011
- Neurodevelopmental effects of prenatal exposure to psychotropic medicationsDepression and Anxiety, 2010
- Manganese exposure and the neuropsychological effect on children and adolescents: a reviewRevista Panamericana de Salud Pública, 2009
- Integrated Disinfection By-Products Research: Assessing Reproductive and Developmental Risks Posed by Complex Disinfection By-Product MixturesJournal of Toxicology and Environmental Health, Part A, 2008
- Research Issues Underlying the Four-Lab Study: Integrated Disinfection By-Products Mixtures ResearchJournal of Toxicology and Environmental Health, Part A, 2008
- Time to Re-evaluate the Guideline Value for Manganese in Drinking Water?Environmental Health Perspectives, 2007
- Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily doseRegulatory Toxicology and Pharmacology, 2004